Access Statistics for Darius Lakdawalla

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aging and the Growth of Long-Term Care 0 0 1 242 0 0 2 1,286
Aging and the Growth of Long-Term Care 0 0 0 29 0 1 1 134
An Economic Evaluation of the War on Cancer 0 0 0 95 0 1 3 354
Are the Young Becoming More Disabled? 0 0 0 93 0 0 0 344
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer 0 0 1 152 0 0 3 538
Does Medicare Benefit the Poor? New Answers to an Old Question 0 0 0 67 0 1 2 375
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 0 0 2 35
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 0 1 3 32
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 2 55 1 8 37 215
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? 0 0 0 5 0 0 2 29
Effects of expanding health screening on treatment – What should we expect? What can we learn? 0 0 1 6 0 0 2 49
Evaluation of Medical Technologies with Uncertain Benefits 0 0 0 48 0 0 5 41
Food Prices and the Dynamics of Body Weight 0 0 3 70 0 1 7 229
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 0 2 629
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses 0 0 0 13 0 0 1 50
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 0 1 1 421
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 1 1 1 189
Insurance and Innovation in Health Care Markets 0 0 1 136 0 0 2 465
Insurance, Self-Protection, and the Economics of Terrorism 0 0 0 287 0 0 0 884
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D 0 0 0 32 2 2 3 145
Insurers' Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 14 0 0 0 95
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 3 0 0 0 69
Intellectual Property and Marketing 0 0 1 91 0 1 15 384
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 0 0 0 122
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 0 1 3 259
International Differences in Longevity and Health and their Economic Consequences 0 0 0 54 0 0 1 167
Mortality Risk, Insurance, and the Value of Life 0 0 2 37 0 0 10 41
Nonprofit Production 0 0 0 0 0 1 7 194
Nonprofit Production and Competition 0 0 1 294 0 0 2 1,230
Optimal Liability for Terrorism 0 0 0 40 1 1 3 211
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 1 1 1 22 1 2 9 83
The Declining Quality of Teachers 0 0 0 220 0 0 2 1,667
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 3 489 0 0 18 1,590
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 1 88 0 0 5 364
The Insurance Value of Medical Innovation 0 0 1 31 0 0 4 95
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 1 233 1 1 2 1,766
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 0 0 1 1 7 765
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 1 29 1 1 3 158
The Welfare Effects of Medical Malpractice Liability 0 0 0 101 0 2 3 461
The Welfare Effects of Public Drug Insurance 0 0 0 77 0 0 0 284
Time-Inconsistency and Welfare 0 0 0 78 0 1 1 368
Understanding Health Disparities Across Education Groups 0 0 0 390 0 1 8 1,681
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 0 0 111
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 0 0 0 177
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 42 0 0 2 222
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market 0 0 0 15 0 4 10 93
Vaccine Allocation Priorities Using Disease Surveillance and Economic Data 0 0 2 2 1 3 11 11
Total Working Papers 1 1 23 4,193 10 37 205 19,112


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies 1 1 2 56 1 1 4 213
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 0 0 0 2 0 0 5 16
A Theory of Health Disparities and Medical Technology 2 2 9 129 5 10 47 554
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) 0 0 0 0 1 1 6 6
An economic evaluation of the war on cancer 1 2 3 104 1 7 22 548
Are Biopharmaceutical Budget Caps Good Public Policy? 0 0 0 12 0 0 4 72
Are investments in disease prevention complements? The case of statins and health behaviors 0 0 1 11 0 0 2 76
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? 0 1 1 35 0 1 2 177
Can the ACA Improve Population Health? 0 0 0 13 0 0 0 63
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer 0 0 1 14 0 1 6 95
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 25 0 1 3 100
Disability Forecasts and Future Medicare Costs 0 0 0 33 0 0 4 267
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets 0 0 0 39 0 1 7 163
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 1 1 1 15
Does Medicare benefit the poor? 0 1 6 127 0 1 13 315
Economics of the Pharmaceutical Industry 4 7 47 262 10 20 101 593
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 0 0 0 20
Geographic Variation in Health Care: The Role of Private Markets 0 0 2 73 3 5 31 387
HIV Breakthroughs and Risky Sexual Behavior 0 0 6 164 1 2 11 901
HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING? 0 0 1 15 0 0 5 281
HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE 0 1 10 93 0 1 17 294
Healing the poor: The influence of patient socioeconomic status on physician supply responses 0 0 0 3 4 6 7 63
Health insurance as a two-part pricing contract 0 1 4 48 0 2 13 353
Health technology assessment with risk aversion in health 0 0 2 6 0 0 6 31
Innovation and the welfare effects of public drug insurance 0 0 0 41 0 0 2 147
Insurance, self-protection, and the economics of terrorism 1 1 7 76 1 1 16 304
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 2 15 1 1 12 128
Is nursing home demand affected by the decline in age difference between spouses? 0 0 0 26 1 1 2 323
Labor Supply and Weight 0 0 3 43 0 0 10 121
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 0 45 0 0 8 174
Pharmaceutical advertising and Medicare Part D 0 0 0 12 0 0 3 143
Predicting quantity and quality of life with the Future Elderly Model 1 1 2 2 1 2 7 7
Public Financing and the Market for Long-Term Care 0 0 0 24 0 0 0 97
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets 0 0 1 14 1 2 4 90
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 1 38 1 2 3 136
Social insurance and the design of innovation incentives 0 0 0 20 0 0 0 84
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 0 67 0 1 5 284
The Economics of Teacher Quality 0 0 0 6 0 1 4 201
The Fiscal Consequences of Trends in Population Health 1 1 1 13 2 2 2 60
The Labor Market Value of Health Improvements 0 0 0 44 0 0 1 151
The Rise in Old-Age Longevity and the Market for Long-Term Care 1 1 2 106 1 2 14 433
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population 0 0 0 1 0 0 8 18
The Value of Diagnostic Testing in Personalized Medicine 0 1 4 57 0 2 12 212
The economics of alternative payment models for pharmaceuticals 0 1 4 6 2 4 12 26
The growth of obesity and technological change 0 0 0 28 1 1 4 116
The insurance value of medical innovation 0 0 3 31 0 2 15 140
The nonprofit sector and industry performance 1 2 8 240 1 3 20 669
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions 0 0 0 3 0 1 2 38
The value of medical and pharmaceutical interventions for reducing obesity 1 1 2 15 1 1 5 93
The welfare effects of medical malpractice liability 0 0 0 14 0 0 3 132
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market* 0 0 0 0 0 1 2 2
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 1 26 0 0 1 100
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 0 0 0 5 11
Welfare-Enhancing Technological Change and the Growth of Obesity 0 0 0 148 1 1 3 418
Total Journal Articles 14 25 136 2,430 42 92 502 10,461


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Disability Forecasts and Future Medicare Costs 1 1 1 22 2 2 3 103
Economics of Obesity 0 0 1 22 0 1 3 80
Economics of Obesity 0 1 2 34 1 2 4 87
Food Prices and the Dynamics of Body Weight 0 0 1 14 1 1 4 68
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 1 1 5 86 2 3 11 220
Medical Care Output and Productivity in the Nonprofit Sector 0 0 0 12 0 0 1 61
Public Financing and the Market for Long-Term Care 0 0 0 8 0 0 0 49
Total Chapters 2 3 10 198 6 9 26 668


Statistics updated 2022-11-05